CCL
68
6
FCX
44
4
KSS
36
2
CINF
24
-8
PHM
44
4
EXPE
83
8
M
40
3
TSCO
42
4
CFG
36
12
EMR
57
7
CLX
65
2
WAT
55
11
STZ
42
2
BAC
38
3
PEG
53
7
PPL
44
9
HPE
48
2
BIIB
36
8
JBHT
46
4
PCG
59
9
CCL
68
6
FCX
44
4
KSS
36
2
CINF
24
-8
PHM
44
4
EXPE
83
8
M
40
3
TSCO
42
4
CFG
36
12
EMR
57
7
CLX
65
2
WAT
55
11
STZ
42
2
BAC
38
3
PEG
53
7
PPL
44
9
HPE
48
2
BIIB
36
8
JBHT
46
4
PCG
59
9
Financhill
Back

Poseida Therapeutics Vs. Phathom Pharmaceuticals Industry Stock Comparison

Sell
48

PSTX
Poseida Therapeutics

Last Price:
$9.47
Seasonality Move:
-14.94%
Sell
15

PHAT
Phathom Pharmaceuticals

Last Price:
$7.45
Seasonality Move:
-9.47%
Sell
48
Poseida Therapeutics (PSTX) is a Sell

Is Poseida Therapeutics a Buy, Sell or Hold?

  • The current Poseida Therapeutics [PSTX] share price is $9.47. The Score for PSTX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • PSTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
15
Phathom Pharmaceuticals (PHAT) is a Sell

Is Phathom Pharmaceuticals a Buy, Sell or Hold?

  • The current Phathom Pharmaceuticals [PHAT] share price is $7.45. The Score for PHAT is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
  • PHAT is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

PSTX Stock Price Chart

What is Poseida Therapeutics's stock price today?

  • The Poseida Therapeutics share price today is $9.47
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PSTX is experiencing buying pressure, which is a positive indicator for future bullish movement.

PHAT Stock Price Chart

What is Phathom Pharmaceuticals's stock price today?

  • The Phathom Pharmaceuticals share price today is $7.45
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PHAT is experiencing selling pressure, which indicates risk of future bearish movement.

PSTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.35 Buy
Relative Strength Index (14 RSI): 86.15 Buy
Chaikin Money Flow: 1458989 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.55 - 10.55) Buy
Bollinger Bands (100): (1.49 - 6.57) Buy

PHAT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.16 Sell
Relative Strength Index (14 RSI): 29.68 Sell
Chaikin Money Flow: -1800545 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.14 - 9.2) Sell
Bollinger Bands (100): (10.05 - 17.69) Sell

PSTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 9.48 Sell
20-day SMA: 8.76 Buy
50-day SMA: 5.12 Buy
200-day SMA: 3.48 Buy
8-day EMA: 9.39 Buy
20-day EMA: 8.35 Buy
50-day EMA: 6.21 Buy
200-day EMA: 3.98 Buy

PHAT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 8.01 Sell
20-day SMA: 8.58 Sell
50-day SMA: 12.23 Sell
200-day SMA: 12.1 Sell
8-day EMA: 8.04 Sell
20-day EMA: 8.9 Sell
50-day EMA: 11.14 Sell
200-day EMA: 12.16 Sell

Poseida Therapeutics Earnings Growth & PSTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.75 per share, and a decrease next year of $1.08 per share.

Phathom Pharmaceuticals Earnings Growth & PHAT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.64 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.94 per share, and an increase next year of $1.13 per share.

Poseida Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Phathom Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):